Study Stopped
Unable to recruit/enroll subjects for study.
Association of Periostin Levels and Chronic Sinusitis
1 other identifier
observational
N/A
1 country
1
Brief Summary
The purpose of this study is to see if a protein in blood, called periostin, can determine if patients have chronic sinusitis. This protein is in everyone's body, but the level of the protein may indicate certain conditions such as chronic sinusitis. The investigators are interested in testing levels of periostin to see if they are higher or lower than patients without chronic sinusitis, just as periostin is higher in patients with asthma. All patients enrolled in this study will have chronic sinusitis without asthma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2014
CompletedFirst Posted
Study publicly available on registry
February 26, 2014
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedMay 4, 2017
May 1, 2017
2 years
February 20, 2014
May 1, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in circulating serum periostin levels pre and post sinus surgery
Serum collected prior to and following sinus surgery will be analyzed for concentrations of the protein periostin.
10-15 weeks
Study Arms (1)
Subjects who require sinus surgery
Interventions
Eligibility Criteria
Subjects who are recommended for sinus surgery as part of their care who self report no asthma.
You may qualify if:
- Patients with sinus disease which requires surgical intervention
- Ability to understand and give informed consent
You may not qualify if:
- Previous diagnosis of asthma
- Positive methacholine challenge at screening
- Diagnosis of cystic fibrosis
- Concomitant use of systemic corticosteroids (except for those prescribed as part of standard pre-surgical treatment)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Virginia
Charlottesville, Virginia, 22908, United States
Biospecimen
Serum and paraffin embedded nasal polyp tissue samples
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 20, 2014
First Posted
February 26, 2014
Study Start
September 1, 2014
Primary Completion
September 1, 2016
Study Completion
October 1, 2016
Last Updated
May 4, 2017
Record last verified: 2017-05